172 related articles for article (PubMed ID: 15129841)
1. The effect of antiepileptic drugs on visual performance.
Hilton EJ; Hosking SL; Betts T
Seizure; 2004 Mar; 13(2):113-28. PubMed ID: 15129841
[TBL] [Abstract][Full Text] [Related]
2. Effects of antiepileptic drugs on visual function, with special reference to Vigabatrin.
Sorri I
Acta Ophthalmol Scand; 2002 Jun; 80(3):343-4. PubMed ID: 12059879
[No Abstract] [Full Text] [Related]
3. Patients treated with vigabatrin exhibit central visual function loss.
Hilton EJ; Cubbidge RP; Hosking SL; Betts T; Comaish IF
Epilepsia; 2002 Nov; 43(11):1351-9. PubMed ID: 12423385
[TBL] [Abstract][Full Text] [Related]
4. A controlled study comparing visual function in patients treated with vigabatrin and tiagabine.
Krauss GL; Johnson MA; Sheth S; Miller NR
J Neurol Neurosurg Psychiatry; 2003 Mar; 74(3):339-43. PubMed ID: 12588920
[TBL] [Abstract][Full Text] [Related]
5. Visual field defects associated with vigabatrin therapy.
Lawden MC; Eke T; Degg C; Harding GF; Wild JM
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):716-22. PubMed ID: 10567485
[TBL] [Abstract][Full Text] [Related]
6. Visual field constriction and electrophysiological changes associated with vigabatrin.
Besch D; Kurtenbach A; Apfelstedt-Sylla E; Sadowski B; Dennig D; Asenbauer C; Zrenner E; Schiefer U
Doc Ophthalmol; 2002 Mar; 104(2):151-70. PubMed ID: 11999623
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.
Sills GJ; Butler E; Forrest G; Ratnaraj N; Patsalos PN; Brodie MJ
Epilepsia; 2003 Jul; 44(7):886-92. PubMed ID: 12823570
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
[TBL] [Abstract][Full Text] [Related]
9. [Visual field defects due to antiepileptic drugs].
Stefan H; Bernatik J; Knorr J
Nervenarzt; 1999 Jun; 70(6):552-5. PubMed ID: 10412701
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.
Krauss GL; Johnson MA; Miller NR
Neurology; 1998 Mar; 50(3):614-8. PubMed ID: 9521245
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic effects of GABA-transaminase inhibitors in the treatment of epilepsy: ocular perfusion and visual performance.
Hosking SL; Hilton EJ
Ophthalmic Physiol Opt; 2002 Sep; 22(5):440-7. PubMed ID: 12358316
[TBL] [Abstract][Full Text] [Related]
12. Visual function loss from vigabatrin: effect of stopping the drug.
Johnson MA; Krauss GL; Miller NR; Medura M; Paul SR
Neurology; 2000 Jul; 55(1):40-5. PubMed ID: 10891902
[TBL] [Abstract][Full Text] [Related]
13. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.
Nousiainen I; Kälviäinen R; Mäntyjärvi M
Ophthalmology; 2000 May; 107(5):884-8. PubMed ID: 10811079
[TBL] [Abstract][Full Text] [Related]
14. [Vigabatrin: balancing effectiveness vs. (irreversible) visual field loss as a side effect].
Hardus P; Engelsman M; van Veelen CW; Stilma JS
Ned Tijdschr Geneeskd; 2000 Oct; 144(43):2066-9. PubMed ID: 11072511
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological Evidences of Visual Field Alterations in Children Exposed to Vigabatrin Early in Life.
Hébert-Lalonde N; Carmant L; Major P; Roy MS; Lassonde M; Saint-Amour D
Pediatr Neurol; 2016 Jun; 59():47-53. PubMed ID: 27105764
[TBL] [Abstract][Full Text] [Related]
16. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
[TBL] [Abstract][Full Text] [Related]
17. Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina.
Sills GJ; Patsalos PN; Butler E; Forrest G; Ratnaraj N; Brodie MJ
Neurology; 2001 Jul; 57(2):196-200. PubMed ID: 11468302
[TBL] [Abstract][Full Text] [Related]
18. Visual field and electrophysiological abnormalities due to vigabatrin.
van der Torren K; Graniewski-Wijnands HS; Polak BC
Doc Ophthalmol; 2002 Mar; 104(2):181-8. PubMed ID: 11999625
[TBL] [Abstract][Full Text] [Related]
19. Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects?
Sorri I; Brigell MG; Mályusz M; Mahlamäki E; de Meynard C; Kälviäinen R
Epilepsy Res; 2010 Nov; 92(1):48-53. PubMed ID: 20850272
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic drugs and visual function.
Verrotti A; Manco R; Matricardi S; Franzoni E; Chiarelli F
Pediatr Neurol; 2007 Jun; 36(6):353-60. PubMed ID: 17560495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
